This Is What Whales Are Betting On Novo Nordisk
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
BofA Securities Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating
Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn't a Problem. -- Barrons.com
Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
Novo Nordisk Shares Unlikely to Move Ahead of New Drug Data -- Market Talk
Novo Nordisk's New Weight-Loss Jab Could Support Co Into 2030s -- Market Talk
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could Be Next
Novo Nordisk Says Co Has Mitigation Plans In Place To Minimize Or Prevent Any Production Disruption Due To The Potential Seaport Strikes
Lilly Looking to Test Zepbound as Health Maintenance Drug: Report
Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
Roche Sees Carmot Obesity Drugs' Potential Peak Sales at $3.6B+: Report
European healthcare stocks ended their October winning streak, causing concerns for companies like novo-nordisk a/s (NVO.US) and other pharmaceutical companies.
European medical care stocks are about to end their longest rising trend since March 2010, due to market concerns about novo-nordisk a/s's upcoming third-quarter performance, as well as experimental drug updates from astrazeneca and roche.
Pharmaceutical industry becomes a key driver, Denmark's GDP growth in the second quarter exceeded expectations by 1.1%.
Denmark's economic growth rate is faster than previously expected.
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent Set to Advance in Top Drug Sales
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
Benzinga Bulls And Bears: Apple, Tesla, Novo Nordisk, Bitcoin — And Shiba Inu's Major Stablecoin Tease
European luxury goods concept stocks saw the largest weekly increase since 2012.
On Friday, September 27, the personal and household products index of the STOXX 600 index rose by 1.77%, marking a fifth consecutive trading day increase, with a total surge of 9.38% for the week. Data shows that among the component stocks, Henkel rose by 10.91% on Friday, Beiersdorf by 6.96%, Yunji Group by 6.34%, Ubisoft Entertainment by 5.94%, and Hugo Boss by 5.45% ranking fifth in performance, while LVMH Group rose by 3.67% ranking ninth in terms of increase. Meanwhile, L'Oreal dropped by 0.66%, marking the largest decrease among the three component stocks that fell. Among the "EU Eleven Heavenly Kings," Novo-Nordisk A/S dropped by 4.59%, while L'Oreal...
European stock markets hit record highs, driven by bets on interest rate cuts.
European stock markets touched record highs on Friday, boosted by increasing market confidence in further interest rate cuts in the USA and the eurozone in the coming months. The Stoxx 600 Index closed up 0.5%, with newly released data reinforcing expectations of further interest rate cuts in the USA. Key US inflation and personal spending indicators, valued by the Fed, edged up slightly in August, highlighting the cooling economy. Luxury goods companies such as LVMH, Hermès International, and Kering Group continued their upward trend in stock prices. The chemical and automotive sectors also performed well. Europe's largest luxury goods stock, LVMH, received additional momentum. According to the announcement, the company will invest in designer residences.